Research ArticleOriginal Article
Open Access

The emergence of carbapenem-resistant Klebsiella pneumoniae isolates producing OXA-48 and NDM in the Southern (Asir) province, Saudi Arabia

Ibrahim A. Al-Zahrani and Bander A. Alasiri
Saudi Medical Journal January 2018, 39 (1) 23-30; DOI: https://doi.org/10.15537/smj.2018.1.21094

References

  1. ↵
    1. Rawat D,
    2. Nair D
    (2010) Extended-spectrum beta-lactamases in Gram Negative Bacteria. J Glob Infect Dis 2:263–274.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Shibl A,
    2. Al-Agamy M,
    3. Memish Z,
    4. Senok A,
    5. Khader SA,
    6. Assiri A
    (2013) The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. Int J Infect Dis 17:e1130–e1133.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Naas T,
    2. Nordmann P
    (1994) Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc Natl Acad Sci U S A 91:7693–7697.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Djahmi N,
    2. Dunyach-Remy C,
    3. Pantel A,
    4. Dekhil M,
    5. Sotto A,
    6. Lavigne JP
    (2014) Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries. Biomed Res Int 2014:305784.
    OpenUrl
  5. ↵
    1. Lee CR,
    2. Lee JH,
    3. Park KS,
    4. Kim YB,
    5. Jeong BC,
    6. Lee SH
    (2016) Global dissemination of carbapenemase-producing Klebsiella pneumoniae: Epidemiology, genetic context, treatment options, and detection methods. Front Microbiol 7:895.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Potron A,
    2. Poirel L,
    3. Rondinaud E,
    4. Nordmann P
    (2013) Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill Euro Surveill 18:20549.
    OpenUrl
  7. ↵
    1. Balkhy HH,
    2. El-Saed A,
    3. Al Johani SM,
    4. Francis C,
    5. Al-Qahtani AA,
    6. Al-Ahdal MN,
    7. et al.
    (2012) The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go? Eur J Clin Microbiol Infect Dis 31:1901–1909.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Zowawi HM,
    2. Balkhy HH,
    3. Walsh TR,
    4. Paterson DL
    (2013) Beta-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev 26:361–380.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Uz Zaman T,
    2. Aldrees M,
    3. Al Johani SM,
    4. Alrodayyan M,
    5. Aldughashem FA,
    6. Balkhy HH
    (2014) Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia. Int J Infect Dis 28:186–192.
    OpenUrlCrossRef
  10. ↵
    1. Zarakolu P,
    2. Eser OK,
    3. Aladag E,
    4. Al-Zahrani IA,
    5. Day KM,
    6. Atmaca O,
    7. et al.
    (2016) Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013. Diagn Microbiol Infect Dis 85:466–470.
    OpenUrlCrossRef
  11. ↵
    1. Pavelkovich A,
    2. Balode A,
    3. Edquist P,
    4. Egorova S,
    5. Ivanova M,
    6. Kaftyreva L,
    7. et al.
    (2014) Detection of carbapenemase-producing enterobacteriaceae in the baltic countries and st. Petersburg area. Biomed Res Int 2014:548960.
    OpenUrl
  12. ↵
    1. Dortet L,
    2. Poirel L,
    3. Al Yaqoubi F,
    4. Nordmann P
    (2012) NDM-1 OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect 18:E144–E148.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Sonnevend A,
    2. Ghazawi AA,
    3. Hashmey R,
    4. Jamal W,
    5. Rotimi VO,
    6. Shibl AM,
    7. et al.
    (2015) Characterization of Carbapenem-Resistant Enterobacteriaceae with High Rate of Autochthonous Transmission in the Arabian Peninsula. PLoS One 10:e0131372.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Kofteridis DP,
    2. Valachis A,
    3. Dimopoulou D,
    4. Maraki S,
    5. Christidou A,
    6. Mantadakis E,
    7. et al.
    (2014) Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study. J Infect Chemother 20:293–297.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Jiao Y,
    2. Qin Y,
    3. Liu J,
    4. Li Q,
    5. Dong Y,
    6. Shang Y,
    7. et al.
    (2015) Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study. Pathog Glob Health 109:68–74.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Tenover FC,
    2. Kalsi RK,
    3. Williams PP,
    4. Carey RB,
    5. Stocker S,
    6. Lonsway D,
    7. et al.
    (2006) Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 12:1209–1213.
    OpenUrlCrossRefPubMedWeb of Science
    1. Bratu S,
    2. Landman D,
    3. Haag R,
    4. Recco R,
    5. Eramo A,
    6. Alam M,
    7. et al.
    (2005) Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 165:1430–1435.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Bobenchik AM,
    2. Deak E,
    3. Hindler JA,
    4. Charlton CL,
    5. Humphries RM
    (2015) Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints. J Clin Microbiol 53:816–823.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Woodford N,
    2. Eastaway AT,
    3. Ford M,
    4. Leanord A,
    5. Keane C,
    6. Quayle RM,
    7. et al.
    (2010) Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae. J Clin Microbiol 48:2999–3002.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Bakthavatchalam YD,
    2. Anandan S,
    3. Veeraraghavan B
    (2016) Laboratory detection and clinical implication of oxacillinase-48 like Carbapenemase: The Hidden Threat. J Glob Infect Dis 8:41–50.
    OpenUrlCrossRef
  21. ↵
    1. Tsakris A,
    2. Poulou A,
    3. Bogaerts P,
    4. Dimitroulia E,
    5. Pournaras S,
    6. Glupczynski Y
    (2015) Evaluation of a new phenotypic OXA-48 disk test for differentiation of OXA-48 carbapenemase-producing Enterobacteriaceae clinical isolates. J Clin Microbiol 53:1245–1251.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Poirel L,
    2. Heritier C,
    3. Tolun V,
    4. Nordmann P
    (2004) Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:15–22.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Jamal WY,
    2. Albert MJ,
    3. Rotimi VO
    (2016) High Prevalence of New Delhi Metallo-beta-Lactamase-1 (NDM-1) Producers among Carbapenem-Resistant Enterobacteriaceae in Kuwait. PLoS One 11:e0152638.
    OpenUrl
  24. ↵
    1. Maurer FP,
    2. Castelberg C,
    3. Quiblier C,
    4. Bloemberg GV,
    5. Hombach M
    (2015) Evaluation of carbapenemase screening and confirmation tests with Enterobacteriaceae and development of a practical diagnostic algorithm. J Clin Microbiol 53:95–104.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Nordmann P,
    2. Poirel L
    (2014) The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20:821–830.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Yigit H,
    2. Queenan AM,
    3. Anderson GJ,
    4. Domenech-Sanchez A,
    5. Biddle JW,
    6. Steward CD,
    7. et al.
    (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Munoz-Price LS,
    2. Poirel L,
    3. Bonomo RA,
    4. Schwaber MJ,
    5. Daikos GL,
    6. Cormican M,
    7. et al.
    (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785–796.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Chen LF,
    2. Anderson DJ,
    3. Paterson DL
    (2012) Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist 5:133–141.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Al-Qadheeb NS,
    2. Althawadi S,
    3. Alkhalaf A,
    4. Hosaini S,
    5. Alrajhi AA
    (2010) Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient. Ann Saudi Med 30:404–407.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    1. Taylor C,
    2. Albasri W
    (2014) The Impact of Saudi Arabia King Abdullah's Scholarship Program in the U.S. Open Journal of Social Sciences 2:109–118.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section